Methods of treating psoriasis using IL-17 Receptor A antibodies
US7833527B2 · kind B2 · utility
17Cited by
21References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2007 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Oct 22, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.